Literature DB >> 25058902

Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) scleral device compared to keratoplasty for the treatment of corneal ectasia.

Karen S DeLoss1, Nadeem H Fatteh1, Christopher T Hood2.   

Abstract

PURPOSE: To compare the ocular characteristics and visual outcomes of eyes with corneal ectasia that were fitted with the Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) scleral device to those that underwent keratoplasty.
DESIGN: Retrospective, comparative case series.
METHODS: We reviewed the charts of consecutive patients with corneal ectasia that were evaluated for PROSE or underwent keratoplasty at our institution. Clinical data, topographic indices, and corneal thickness were reviewed, and eyes were stratified according to the Amsler-Krumeich classification for severity of ectasia. Only the more severe eye of each patient was included in the study. We compared visual acuity before and after PROSE fitting or keratoplasty. For PROSE evaluations, achievement of satisfactory fit and continued wear at 1 year of follow-up were recorded.
RESULTS: From 2010 to 2012, 36 patients underwent PROSE evaluation for corneal ectasia while 37 patients underwent keratoplasty for the same indication. All eyes were successfully fitted with the PROSE device. Eyes in the keratoplasty group had more severe ectasia than eyes in the PROSE group (P = .038). Visual acuity was achieved more rapidly in the PROSE cohort compared to keratoplasty, and mean visual acuity was significantly better for all eyes (P < .0001) and when including only eyes with stage 4 ectasia (P < .001). More eyes with stage 4 ectasia achieved 20/25 visual acuity after PROSE than after keratoplasty (P = .003). At 1 year follow-up in the PROSE cohort, Snellen acuity was 20/28 (P = .108 vs keratoplasty), improving to 20/25 with over-refraction (P = .006 vs keratoplasty).
CONCLUSIONS: Eyes with advanced corneal ectasia can be successfully fitted with the PROSE device, and the visual acuity outcome for stage 4 ectasia was better and more rapid compared to keratoplasty. The acuity remained excellent with 1 year of follow-up. PROSE evaluation should be considered in patients with advanced corneal ectasia before proceeding to keratoplasty, especially if the ectasia is deemed stable.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25058902     DOI: 10.1016/j.ajo.2014.07.016

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Long-term outcome of using Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) as a drug delivery system for bevacizumab in the treatment of corneal neovascularization.

Authors:  Jia Yin; Deborah S Jacobs
Journal:  Ocul Surf       Date:  2018-11-20       Impact factor: 5.033

2.  Impact of Scleral Contact Lens Use on the Rate of Corneal Transplantation for Keratoconus.

Authors:  Jennifer J Ling; Shahzad I Mian; Joshua D Stein; Moshiur Rahman; Joel Poliskey; Maria A Woodward
Journal:  Cornea       Date:  2021-01       Impact factor: 3.152

3.  Visual management of aphakia with concomitant severe corneal irregularity by mini-scleral design contact lenses.

Authors:  Fateme Alipur; Seyedeh Simindokht Hosseini
Journal:  J Curr Ophthalmol       Date:  2016-03-30

4.  Prevalence of Ocular Surface Disease and Corneal Irregularity and Outcomes in Patients Using Therapeutic Scleral Lenses at a Tertiary Care Center.

Authors:  Angelica C Scanzera; Sneha Bontu; Charlotte E Joslin; Timothy McMahon; Mark Rosenblatt; Ellen Shorter
Journal:  Eye Contact Lens       Date:  2020-11       Impact factor: 2.018

Review 5.  Scleral lens for keratoconus: technology update.

Authors:  Varsha M Rathi; Preeji S Mandathara; Mukesh Taneja; Srikanth Dumpati; Virender S Sangwan
Journal:  Clin Ophthalmol       Date:  2015-10-28

6.  Prosthetic replacement of the ocular surface ecosystem: impact at 5 years.

Authors:  Joshua S Agranat; Nicole R Kitos; Deborah S Jacobs
Journal:  Br J Ophthalmol       Date:  2015-12-07       Impact factor: 4.638

7.  Improvement of chronic corneal opacity in ocular surface disease with prosthetic replacement of the ocular surface ecosystem (PROSE) treatment.

Authors:  Anna Cressey; Deborah S Jacobs; Crystal Remington; Karen G Carrasquillo
Journal:  Am J Ophthalmol Case Rep       Date:  2018-02-15

8.  Update on Contact Lens Treatment of Keratoconus

Authors:  Tomris Şengör; Sevda Aydın Kurna
Journal:  Turk J Ophthalmol       Date:  2020-08-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.